Centro Hospitalar de Entre o Douro e Vouga, E.P.E - Hospital de São Sebastião

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Lung cancer1 trial
• Metastatic breast cancer1 trial

Phase

• Phase 32 trials

Status

• Completed2 trials

Lead sponsor

• Daiichi Sankyo1 trial
• EMD Serono Research & Development Institute, Inc.1 trial

Closed trials

• Completed

  Trastuzumab Deruxtecan (DS-8201a) Versus Investigator's Choice for HER2-low Breast Cancer That Has Spread or Cannot be Surgically Removed [DESTINY-Breast04]

  NCT03734029· Phase 3· Daiichi Sankyo· Source

• Completed

  Avelumab in First-line NSCLC (JAVELIN Lung 100)

  NCT02576574· Phase 3· EMD Serono Research & Development Institute, Inc.· Source